Table of Contents
Table of Contents 2
List of Tables 5
List of Figures 5
Nanotherapeutics, Inc. Snapshot 6
Nanotherapeutics, Inc. Overview 6
Key Information 6
Key Facts 6
Nanotherapeutics, Inc. - Research and Development Overview 7
Key Therapeutic Areas 7
Nanotherapeutics, Inc. - Pipeline Review 10
Pipeline Products by Stage of Development 10
Pipeline Products - Monotherapy 11
Pipeline Products - Combination Treatment Modalities 12
Pipeline Products - Partnered Products 13
Partnered Products/Combination Treatment Modalities 14
Nanotherapeutics, Inc. - Pipeline Products Glance 15
Nanotherapeutics, Inc. - Late Stage Pipeline Products 15
Pre-Registration Products/Combination Treatment Modalities 15
Phase III Products/Combination Treatment Modalities 16
Nanotherapeutics, Inc. - Clinical Stage Pipeline Products 17
Phase II Products/Combination Treatment Modalities 17
Phase I Products/Combination Treatment Modalities 18
Nanotherapeutics, Inc. - Early Stage Pipeline Products 19
Preclinical Products/Combination Treatment Modalities 19
Nanotherapeutics, Inc. - Drug Profiles 20
influenza [strains A/H1N1 + A/H3N2 + B] (trivalent, split virion) vaccine 20
Product Description 20
Mechanism of Action 20
R&D Progress 20
ross river virus vaccine 21
Product Description 21
Mechanism of Action 21
R&D Progress 21
(buprenorphine hydrochloride + naloxone hydrochloride) 23
Product Description 23
Mechanism of Action 23
R&D Progress 23
influenza [strain A/H9N2] vaccine 24
Product Description 24
Mechanism of Action 24
R&D Progress 24
NTC-942 26
Product Description 26
Mechanism of Action 26
R&D Progress 26
NTO-1151 27
Product Description 27
Mechanism of Action 27
R&D Progress 27
ramoplanin 29
Product Description 29
Mechanism of Action 29
R&D Progress 29
influenza [strain A/H5N1] vaccine 30
Product Description 30
Mechanism of Action 30
R&D Progress 30
West Nile virus vaccine 31
Product Description 31
Mechanism of Action 31
R&D Progress 31
XOMA-3AB 32
Product Description 32
Mechanism of Action 32
R&D Progress 32
chikungunya vaccine 33
Product Description 33
Mechanism of Action 33
R&D Progress 33
influenza [strain A/H7N9] vaccine 34
Product Description 34
Mechanism of Action 34
R&D Progress 34
middle east respiratory syndrome vaccine + severe acute respiratory syndrome vaccine 35
Product Description 35
Mechanism of Action 35
R&D Progress 35
norovirus (bivalent) virus like particle vaccine 36
Product Description 36
Mechanism of Action 36
R&D Progress 36
Rotavirus vaccine 37
Product Description 37
Mechanism of Action 37
R&D Progress 37
typhoid vaccine 38
Product Description 38
Mechanism of Action 38
R&D Progress 38
Nanotherapeutics, Inc. - Pipeline Analysis 39
Nanotherapeutics, Inc. - Pipeline Products by Target 39
Nanotherapeutics, Inc. - Pipeline Products by Route of Administration 40
Nanotherapeutics, Inc. - Pipeline Products by Molecule Type 41
Nanotherapeutics, Inc. - Pipeline Products by Mechanism of Action 42
Nanotherapeutics, Inc. - Recent Pipeline Updates 43
Nanotherapeutics, Inc. - Dormant Projects 46
Nanotherapeutics, Inc. - Locations And Subsidiaries 47
Head Office 47
Other Locations & Subsidiaries 47
Appendix 48
Methodology 48
Coverage 48
Secondary Research 48
Primary Research 48
Expert Panel Validation 48
Contact Us 48
Disclaimer 49
List of Tables
Nanotherapeutics, Inc., Key Information 6
Nanotherapeutics, Inc., Key Facts 6
Nanotherapeutics, Inc. - Pipeline by Indication, 2016 8
Nanotherapeutics, Inc. - Pipeline by Stage of Development, 2016 10
Nanotherapeutics, Inc. - Monotherapy Products in Pipeline, 2016 11
Nanotherapeutics, Inc. - Combination Treatment Modalities in Pipeline, 2016 12
Nanotherapeutics, Inc. - Partnered Products in Pipeline, 2016 13
Nanotherapeutics, Inc. - Partnered Products/ Combination Treatment Modalities, 2016 14
Nanotherapeutics, Inc. - Pre-Registration, 2016 15
Nanotherapeutics, Inc. - Phase III, 2016 16
Nanotherapeutics, Inc. - Phase II, 2016 17
Nanotherapeutics, Inc. - Phase I, 2016 18
Nanotherapeutics, Inc. - Preclinical, 2016 19
Nanotherapeutics, Inc. - Pipeline by Target, 2016 39
Nanotherapeutics, Inc. - Pipeline by Route of Administration, 2016 40
Nanotherapeutics, Inc. - Pipeline by Molecule Type, 2016 41
Nanotherapeutics, Inc. - Pipeline Products by Mechanism of Action, 2016 42
Nanotherapeutics, Inc. - Recent Pipeline Updates, 2016 43
Nanotherapeutics, Inc. - Dormant Developmental Projects,2016 46
Nanotherapeutics, Inc., Other Locations 47
List of Figures
Nanotherapeutics, Inc. - Pipeline by Top 10 Indication, 2016 8
Nanotherapeutics, Inc. - Pipeline by Stage of Development, 2016 10
Nanotherapeutics, Inc. - Monotherapy Products in Pipeline, 2016 11
Nanotherapeutics, Inc. - Combination Treatment Modalities in Pipeline, 2016 12
Nanotherapeutics, Inc. - Pipeline by Target, 2016 39
Nanotherapeutics, Inc. - Pipeline by Route of Administration, 2016 40
Nanotherapeutics, Inc. - Pipeline by Molecule Type, 2016 41
Nanotherapeutics, Inc. - Pipeline Products by Mechanism of Action, 2016 42